Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| General Surgery | 16 | 2025 | 202 | 3.400 |
Why?
|
| Rectal Neoplasms | 7 | 2022 | 99 | 2.930 |
Why?
|
| Internship and Residency | 19 | 2025 | 784 | 2.880 |
Why?
|
| Colorectal Neoplasms | 9 | 2022 | 278 | 2.610 |
Why?
|
| Colectomy | 7 | 2025 | 108 | 2.560 |
Why?
|
| Postoperative Complications | 16 | 2025 | 1261 | 2.260 |
Why?
|
| Surgeons | 8 | 2023 | 173 | 2.100 |
Why?
|
| Colorectal Surgery | 5 | 2025 | 54 | 1.660 |
Why?
|
| Faculty, Medical | 4 | 2025 | 197 | 1.650 |
Why?
|
| Time-to-Treatment | 4 | 2021 | 108 | 1.630 |
Why?
|
| Fellowships and Scholarships | 5 | 2025 | 101 | 1.610 |
Why?
|
| Hospitals, High-Volume | 5 | 2021 | 32 | 1.520 |
Why?
|
| Colonic Neoplasms | 3 | 2023 | 218 | 1.380 |
Why?
|
| Education, Medical, Graduate | 13 | 2025 | 338 | 1.230 |
Why?
|
| Career Mobility | 3 | 2018 | 64 | 1.200 |
Why?
|
| New York | 11 | 2020 | 142 | 1.140 |
Why?
|
| Personnel Selection | 3 | 2025 | 54 | 1.140 |
Why?
|
| Gallbladder Diseases | 3 | 2016 | 25 | 1.100 |
Why?
|
| Minority Groups | 3 | 2023 | 139 | 1.080 |
Why?
|
| Mobile Applications | 3 | 2017 | 136 | 1.080 |
Why?
|
| Cholecystectomy, Laparoscopic | 3 | 2016 | 50 | 1.070 |
Why?
|
| Patient Readmission | 5 | 2025 | 427 | 1.030 |
Why?
|
| Quality Improvement | 5 | 2025 | 433 | 1.020 |
Why?
|
| Surgical Stapling | 2 | 2024 | 12 | 1.020 |
Why?
|
| Anastomosis, Surgical | 2 | 2024 | 110 | 0.980 |
Why?
|
| Male | 48 | 2025 | 29368 | 0.970 |
Why?
|
| Correspondence as Topic | 1 | 2025 | 10 | 0.940 |
Why?
|
| Robotic Surgical Procedures | 4 | 2021 | 138 | 0.920 |
Why?
|
| Rectum | 4 | 2024 | 88 | 0.900 |
Why?
|
| Incisional Hernia | 1 | 2024 | 12 | 0.900 |
Why?
|
| Humans | 66 | 2025 | 62457 | 0.890 |
Why?
|
| Ileostomy | 3 | 2022 | 25 | 0.890 |
Why?
|
| Career Choice | 6 | 2025 | 128 | 0.870 |
Why?
|
| Specialties, Surgical | 3 | 2025 | 47 | 0.870 |
Why?
|
| Patient Discharge | 3 | 2025 | 505 | 0.860 |
Why?
|
| Stress, Psychological | 2 | 2018 | 469 | 0.860 |
Why?
|
| Female | 48 | 2025 | 32378 | 0.860 |
Why?
|
| Lymphoma | 1 | 2023 | 101 | 0.790 |
Why?
|
| Middle Aged | 31 | 2025 | 17294 | 0.790 |
Why?
|
| Attitude of Health Personnel | 4 | 2021 | 583 | 0.780 |
Why?
|
| Schools, Medical | 3 | 2018 | 145 | 0.770 |
Why?
|
| Retrospective Studies | 21 | 2025 | 6486 | 0.760 |
Why?
|
| Laparoscopy | 8 | 2024 | 461 | 0.760 |
Why?
|
| Travel | 2 | 2021 | 40 | 0.750 |
Why?
|
| Adenocarcinoma | 2 | 2021 | 334 | 0.750 |
Why?
|
| Personnel Turnover | 2 | 2018 | 21 | 0.740 |
Why?
|
| Physicians, Women | 2 | 2025 | 39 | 0.740 |
Why?
|
| Transanal Endoscopic Surgery | 1 | 2021 | 23 | 0.730 |
Why?
|
| Obesity, Morbid | 3 | 2018 | 97 | 0.720 |
Why?
|
| Intestinal Obstruction | 2 | 2020 | 53 | 0.700 |
Why?
|
| Postoperative Period | 2 | 2017 | 137 | 0.670 |
Why?
|
| Aged | 26 | 2025 | 14203 | 0.660 |
Why?
|
| Quality of Health Care | 2 | 2021 | 516 | 0.650 |
Why?
|
| Adult | 27 | 2025 | 16567 | 0.640 |
Why?
|
| Surveys and Questionnaires | 8 | 2021 | 2638 | 0.630 |
Why?
|
| Motivation | 2 | 2018 | 283 | 0.610 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 549 | 0.610 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 26 | 0.590 |
Why?
|
| Intraoperative Complications | 2 | 2018 | 89 | 0.590 |
Why?
|
| Infliximab | 1 | 2018 | 49 | 0.590 |
Why?
|
| United States | 19 | 2025 | 7696 | 0.580 |
Why?
|
| Follow-Up Studies | 10 | 2024 | 2439 | 0.570 |
Why?
|
| Time Out, Healthcare | 1 | 2017 | 1 | 0.560 |
Why?
|
| Colitis, Ulcerative | 1 | 2018 | 75 | 0.560 |
Why?
|
| Physician's Role | 1 | 2018 | 124 | 0.550 |
Why?
|
| Confidentiality | 1 | 2017 | 52 | 0.550 |
Why?
|
| Colostomy | 1 | 2017 | 24 | 0.550 |
Why?
|
| Clinical Competence | 9 | 2025 | 711 | 0.540 |
Why?
|
| Electrodes, Implanted | 1 | 2017 | 37 | 0.540 |
Why?
|
| Treatment Outcome | 13 | 2024 | 5554 | 0.540 |
Why?
|
| Electric Stimulation Therapy | 1 | 2017 | 27 | 0.540 |
Why?
|
| Surgery Department, Hospital | 1 | 2016 | 20 | 0.530 |
Why?
|
| Fecal Incontinence | 1 | 2017 | 29 | 0.530 |
Why?
|
| Biological Products | 1 | 2018 | 95 | 0.530 |
Why?
|
| Hepatectomy | 1 | 2017 | 63 | 0.530 |
Why?
|
| Racism | 1 | 2018 | 87 | 0.530 |
Why?
|
| Cultural Diversity | 1 | 2017 | 53 | 0.520 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 265 | 0.520 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 334 | 0.520 |
Why?
|
| Teaching Rounds | 1 | 2016 | 11 | 0.510 |
Why?
|
| Digestive System Surgical Procedures | 4 | 2017 | 90 | 0.490 |
Why?
|
| Telemedicine | 2 | 2017 | 318 | 0.490 |
Why?
|
| Self Care | 1 | 2017 | 212 | 0.480 |
Why?
|
| Time Factors | 6 | 2025 | 3737 | 0.480 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2022 | 706 | 0.470 |
Why?
|
| Leadership | 1 | 2017 | 203 | 0.470 |
Why?
|
| Patient Participation | 1 | 2017 | 229 | 0.470 |
Why?
|
| Palliative Care | 1 | 2017 | 226 | 0.460 |
Why?
|
| Operating Rooms | 1 | 2015 | 55 | 0.460 |
Why?
|
| Students, Medical | 1 | 2017 | 255 | 0.450 |
Why?
|
| Stents | 2 | 2020 | 485 | 0.440 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 293 | 0.440 |
Why?
|
| Neoplasm Staging | 5 | 2023 | 485 | 0.440 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 431 | 0.430 |
Why?
|
| Risk Assessment | 2 | 2016 | 2033 | 0.400 |
Why?
|
| Computer Simulation | 1 | 2015 | 476 | 0.400 |
Why?
|
| Patient Care Team | 1 | 2015 | 335 | 0.390 |
Why?
|
| Colon | 3 | 2024 | 141 | 0.390 |
Why?
|
| Gastrectomy | 3 | 2018 | 39 | 0.380 |
Why?
|
| Qualitative Research | 3 | 2025 | 667 | 0.380 |
Why?
|
| Logistic Models | 6 | 2021 | 1272 | 0.370 |
Why?
|
| Combined Modality Therapy | 3 | 2021 | 365 | 0.350 |
Why?
|
| Disease-Free Survival | 2 | 2021 | 240 | 0.340 |
Why?
|
| Anastomotic Leak | 2 | 2024 | 33 | 0.330 |
Why?
|
| Hospitalization | 2 | 2016 | 1338 | 0.330 |
Why?
|
| Length of Stay | 3 | 2025 | 797 | 0.310 |
Why?
|
| Grounded Theory | 2 | 2018 | 18 | 0.300 |
Why?
|
| Hospital Mortality | 4 | 2017 | 864 | 0.290 |
Why?
|
| Elective Surgical Procedures | 2 | 2025 | 116 | 0.280 |
Why?
|
| Aged, 80 and over | 11 | 2020 | 5390 | 0.280 |
Why?
|
| Databases, Factual | 4 | 2018 | 851 | 0.270 |
Why?
|
| Cohort Studies | 4 | 2018 | 2530 | 0.270 |
Why?
|
| Prospective Studies | 6 | 2022 | 3246 | 0.270 |
Why?
|
| Reoperation | 2 | 2018 | 286 | 0.260 |
Why?
|
| Propensity Score | 2 | 2025 | 154 | 0.260 |
Why?
|
| Social Support | 2 | 2018 | 370 | 0.240 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2024 | 110 | 0.240 |
Why?
|
| Diverticulitis, Colonic | 1 | 2024 | 32 | 0.230 |
Why?
|
| Endocrine Surgical Procedures | 1 | 2023 | 1 | 0.220 |
Why?
|
| Risk Factors | 5 | 2024 | 5288 | 0.220 |
Why?
|
| Academic Medical Centers | 4 | 2023 | 315 | 0.210 |
Why?
|
| Lymph Node Excision | 1 | 2023 | 42 | 0.210 |
Why?
|
| Age Factors | 5 | 2018 | 1552 | 0.200 |
Why?
|
| School Admission Criteria | 1 | 2022 | 8 | 0.200 |
Why?
|
| Lymph Nodes | 1 | 2023 | 222 | 0.190 |
Why?
|
| Prognosis | 3 | 2023 | 1716 | 0.190 |
Why?
|
| Young Adult | 9 | 2019 | 4610 | 0.190 |
Why?
|
| Academic Failure | 2 | 2018 | 2 | 0.190 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2011 | 35 | 0.180 |
Why?
|
| Aging | 2 | 2018 | 738 | 0.180 |
Why?
|
| Colonoscopy | 1 | 2021 | 96 | 0.180 |
Why?
|
| Gastric Bypass | 2 | 2018 | 76 | 0.170 |
Why?
|
| Linear Models | 2 | 2018 | 408 | 0.170 |
Why?
|
| Weight Loss | 3 | 2018 | 272 | 0.170 |
Why?
|
| Educational Measurement | 2 | 2018 | 216 | 0.160 |
Why?
|
| Hospitals, Low-Volume | 2 | 2016 | 18 | 0.160 |
Why?
|
| Regional Health Planning | 1 | 2019 | 10 | 0.160 |
Why?
|
| Massachusetts | 1 | 2025 | 2061 | 0.150 |
Why?
|
| Models, Statistical | 2 | 2017 | 307 | 0.150 |
Why?
|
| Life Change Events | 1 | 2018 | 66 | 0.150 |
Why?
|
| Perioperative Period | 1 | 2018 | 20 | 0.150 |
Why?
|
| Quality of Life | 4 | 2020 | 1216 | 0.150 |
Why?
|
| Appendectomy | 1 | 2018 | 52 | 0.140 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 28 | 0.140 |
Why?
|
| Health Care Surveys | 1 | 2019 | 284 | 0.140 |
Why?
|
| Video-Assisted Surgery | 1 | 2017 | 10 | 0.140 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2017 | 6 | 0.140 |
Why?
|
| Computer Security | 1 | 2017 | 13 | 0.140 |
Why?
|
| Fees and Charges | 1 | 2017 | 17 | 0.140 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2017 | 31 | 0.140 |
Why?
|
| Biliopancreatic Diversion | 1 | 2017 | 2 | 0.140 |
Why?
|
| Appendicitis | 1 | 2018 | 78 | 0.140 |
Why?
|
| Standard of Care | 1 | 2017 | 27 | 0.140 |
Why?
|
| Duodenum | 1 | 2017 | 42 | 0.130 |
Why?
|
| Observer Variation | 1 | 2017 | 211 | 0.130 |
Why?
|
| Emergencies | 1 | 2017 | 116 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2017 | 561 | 0.130 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 53 | 0.130 |
Why?
|
| Morbidity | 1 | 2016 | 113 | 0.130 |
Why?
|
| Device Removal | 1 | 2017 | 65 | 0.130 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 34 | 0.130 |
Why?
|
| Interviews as Topic | 1 | 2018 | 505 | 0.130 |
Why?
|
| Income | 1 | 2017 | 169 | 0.130 |
Why?
|
| Comorbidity | 2 | 2017 | 1117 | 0.130 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2016 | 67 | 0.130 |
Why?
|
| Hospitals, University | 1 | 2016 | 54 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 104 | 0.130 |
Why?
|
| Educational Status | 1 | 2017 | 273 | 0.130 |
Why?
|
| Pandemics | 1 | 2021 | 661 | 0.130 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2016 | 33 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2016 | 252 | 0.120 |
Why?
|
| Incidence | 4 | 2024 | 1359 | 0.120 |
Why?
|
| Anal Canal | 1 | 2016 | 35 | 0.120 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 490 | 0.120 |
Why?
|
| Adolescent | 5 | 2019 | 6147 | 0.120 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 89 | 0.120 |
Why?
|
| Surgical Wound Infection | 1 | 2016 | 112 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 775 | 0.110 |
Why?
|
| Esophageal Achalasia | 1 | 2015 | 35 | 0.110 |
Why?
|
| Cholecystitis, Acute | 1 | 2014 | 29 | 0.110 |
Why?
|
| Esophagus | 1 | 2014 | 50 | 0.110 |
Why?
|
| Operative Time | 1 | 2014 | 87 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 428 | 0.110 |
Why?
|
| Anxiety | 1 | 2018 | 421 | 0.110 |
Why?
|
| Societies, Medical | 1 | 2016 | 362 | 0.110 |
Why?
|
| Sex Factors | 1 | 2017 | 968 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2014 | 77 | 0.110 |
Why?
|
| Patient Safety | 1 | 2016 | 242 | 0.110 |
Why?
|
| Acute Disease | 1 | 2014 | 670 | 0.100 |
Why?
|
| Risk Adjustment | 1 | 2012 | 93 | 0.100 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2011 | 6 | 0.090 |
Why?
|
| Nose Neoplasms | 1 | 2011 | 17 | 0.090 |
Why?
|
| Global Health | 1 | 2012 | 182 | 0.090 |
Why?
|
| Radiotherapy | 1 | 2011 | 64 | 0.090 |
Why?
|
| Hypertension | 1 | 2016 | 590 | 0.090 |
Why?
|
| Radiosurgery | 1 | 2011 | 62 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2019 | 983 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 237 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 255 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 687 | 0.080 |
Why?
|
| Pregnancy | 1 | 2016 | 2308 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 339 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1537 | 0.060 |
Why?
|
| New York City | 2 | 2017 | 79 | 0.060 |
Why?
|
| Obesity | 1 | 2014 | 1227 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1247 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1064 | 0.060 |
Why?
|
| Survival Rate | 2 | 2020 | 837 | 0.060 |
Why?
|
| Sexism | 1 | 2023 | 30 | 0.050 |
Why?
|
| Recurrence | 1 | 2024 | 630 | 0.050 |
Why?
|
| Accreditation | 1 | 2022 | 76 | 0.050 |
Why?
|
| Chemoradiotherapy | 1 | 2022 | 64 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 78 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2017 | 861 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 158 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2020 | 768 | 0.040 |
Why?
|
| Feedback | 1 | 2017 | 89 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 1 | 2018 | 92 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2017 | 87 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 532 | 0.030 |
Why?
|
| Job Satisfaction | 1 | 2018 | 136 | 0.030 |
Why?
|
| SEER Program | 1 | 2017 | 74 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 104 | 0.030 |
Why?
|
| Age of Onset | 1 | 2017 | 175 | 0.030 |
Why?
|
| Registries | 1 | 2020 | 869 | 0.030 |
Why?
|
| Body Composition | 1 | 2017 | 152 | 0.030 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 142 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 497 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 212 | 0.030 |
Why?
|
| Perineum | 1 | 2016 | 20 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 392 | 0.030 |
Why?
|
| Abdomen | 1 | 2016 | 92 | 0.030 |
Why?
|
| Manometry | 1 | 2015 | 27 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2017 | 358 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2017 | 295 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2014 | 118 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 138 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 187 | 0.030 |
Why?
|
| International Educational Exchange | 1 | 2012 | 2 | 0.030 |
Why?
|
| Lymphatic Irradiation | 1 | 2011 | 2 | 0.020 |
Why?
|
| Nasal Cavity | 1 | 2011 | 10 | 0.020 |
Why?
|
| Stomatitis | 1 | 2011 | 7 | 0.020 |
Why?
|
| Radiodermatitis | 1 | 2011 | 11 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2529 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2011 | 86 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2011 | 24 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2011 | 42 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2011 | 63 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 42 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 196 | 0.020 |
Why?
|
| Depression | 1 | 2017 | 883 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 308 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 2571 | 0.020 |
Why?
|
| Child | 1 | 2011 | 4429 | 0.010 |
Why?
|